Nonmelanoma skin cancer tied to lower Alzheimer's risk

May 16, 2013
Nonmelanoma skin cancer tied to lower alzheimer's risk
Older individuals with nonmelanoma skin cancer seem to have a significantly reduced risk of developing Alzheimer's disease, according to a study published online May 15 in Neurology.

(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.

Robert S. White, from the College of Medicine in Bronx, N.Y., and colleagues examined the correlation of NMSC and AD using data from annual assessment for 1,102 community-residing adults (mean age, 79 years at enrollment). Correlations were examined in three nested outcomes groups: only AD (probable or possible AD as the sole diagnosis); any AD (probable AD or possible AD, as well as mixed AD/); and all-cause dementia.

The researchers found that, after adjustment for demographics, hypertension, diabetes, and , prevalent NMSC correlated with a significantly reduced risk of only AD (hazard ratio, 0.21). For 769 individuals, APOE ε4 genotypes were available. When the number of APOE ε4 alleles was included in the model the association was similar in magnitude, but was no longer significant. NMSC was not significantly associated with subsequent development of any AD or all-cause dementia.

"We deduce Alzheimer's-specific , because the effect is attenuated or eliminated when considering less-specific diagnoses such as AD with another diagnosis (any AD) or all-cause dementia," the authors write. "Further investigation is necessary to elucidate the biological and psychosocial basis for the reduced Alzheimer's risk associated with NMSC."

Several authors disclosed financial ties to the pharmaceutical and cognitive technology industries.

Explore further: Drugs targeting blood vessels may be candidates for treating Alzheimer's

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Drugs targeting blood vessels may be candidates for treating Alzheimer's

March 7, 2013
(Medical Xpress)—University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein ...

Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype

January 16, 2012
A sedentary lifestyle is associated with greater cerebral amyloid deposition, which is characteristic of Alzheimer’s disease (AD), among cognitively normal individuals with the ε4 allele of the apolipoprotein E ...

Timing of hormone therapy use impacts alzheimer's risk

October 25, 2012
(HealthDay)—Use of hormone therapy (HT) within five years of menopause is associated with a reduction in the risk of Alzheimer's disease (AD), according to a study published online Oct. 24 in Neurology.

Another potential risk factor for developing dementia and Alzheimer's disease in women

January 2, 2012
A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives ...

Family history of Alzheimer's affects functional connectivity

May 26, 2012
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, and this effect ...

Recommended for you

Lifestyle changes to stave off Alzheimer's? Hints, no proof

July 20, 2017
There are no proven ways to stave off Alzheimer's, but a new report raises the prospect that avoiding nine key risks starting in childhood just might delay or even prevent about a third of dementia cases around the world.

Blood test identifies key Alzheimer's marker

July 19, 2017
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid in their ...

Steering an enzyme's 'scissors' shows potential for stopping Alzheimer's disease

July 19, 2017
The old real estate adage about "location, location, location" might also apply to the biochemical genesis of Alzheimer's disease, according to new research from the University of British Columbia.

Brain scans may change care for some people with memory loss

July 19, 2017
Does it really take an expensive brain scan to diagnose Alzheimer's? Not everybody needs one but new research suggests that for a surprising number of patients whose memory problems are hard to pin down, PET scans may lead ...

Can poor sleep boost odds for Alzheimer's?

July 18, 2017
(HealthDay)— Breathing problems during sleep may signal an increased risk for Alzheimer's disease, a trio of studies suggests.

Hearing is believing: Speech may be a clue to mental decline

July 17, 2017
Your speech may, um, help reveal if you're uh ... developing thinking problems. More pauses, filler words and other verbal changes might be an early sign of mental decline, which can lead to Alzheimer's disease, a study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.